已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

托法替尼 医学 溃疡性结肠炎 内科学 皮肤病科 胃肠病学 结肠炎 类风湿性关节炎 疾病
作者
Kevin Winthrop,Séverine Vermeire,Millie D. Long,Julián Panés,Siew C. Ng,Nicole Kulisek,Rajiv Mundayat,Nervin Lawendy,Ivana Vranić,Irene Modesto,Chinyu Su,Gil Y. Melmed
出处
期刊:Inflammatory Bowel Diseases [Oxford University Press]
卷期号:29 (1): 85-96 被引量:18
标识
DOI:10.1093/ibd/izac063
摘要

Abstract Background Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We report herpes zoster (HZ) incidence and risk factors in the tofacitinib UC clinical program (up to 7.8 years). Methods Proportions and incidence rates (IRs; unique patients with events/100 patient-years) of HZ were evaluated in 4 cohorts: Induction (phase 2 and 3 induction study data), Maintenance (phase 3 maintenance study data), Overall (data from all phase 2, 3, and open-label, long-term extension studies), and Overall plus interim 6-month phase 3b and 4 data. Herpes zoster risk factors were assessed by Cox regression analysis. Results In the Induction and Maintenance Cohorts, IRs for HZ (nonserious and serious) were numerically higher with tofacitinib 10 mg twice daily (BID) vs placebo and tofacitinib 10 vs 5 mg BID, respectively. With all tofacitinib doses (5 or 10 mg BID), IRs (95% confidence intervals) for HZ in the Overall and Overall plus phase 3b/4 Cohorts (total exposure, 2814.4 and 2999.7 patient-years, respectively) were 3.38 (2.73-4.15) and 3.30 (2.67-4.04), respectively. In the Overall plus phase 3b/4 Cohort, >90% of HZ were nonserious; >90% were mild/moderate; >90% resolved without discontinuing tofacitinib; 0.6% of patients had multiple HZ events. Herpes zoster IRs were stable when analyzed by 6-month intervals up to >30 months. Herpes zoster risk factors included older age, lower weight, geographic region, and prior tumor necrosis factor inhibitor (TNFi) failure. Conclusions Most HZ events were mild/moderate. Herpes zoster IRs remained stable over 7.8 years of exposure. Older age, lower weight, geographic region, and prior TNFi failure were associated with increased HZ risk. ClinicalTrials.gov NCT00787202;NCT01465763;NCT01458951;NCT01458574;NCT01470612;NCT03281304
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
耷拉地啦完成签到,获得积分10
5秒前
初昀杭完成签到 ,获得积分10
10秒前
晓书完成签到 ,获得积分10
11秒前
18秒前
Ultraman45发布了新的文献求助10
18秒前
JamesPei应助林佳一采纳,获得10
19秒前
科研小白完成签到 ,获得积分10
19秒前
正直蜗牛完成签到,获得积分10
19秒前
Akim应助白日梦采纳,获得10
20秒前
22秒前
小澜孩完成签到,获得积分10
22秒前
小澜孩发布了新的文献求助10
25秒前
29秒前
科目三应助彼岸花开采纳,获得50
30秒前
32秒前
白日梦发布了新的文献求助10
36秒前
cy0824完成签到 ,获得积分10
38秒前
Omni完成签到,获得积分10
41秒前
胡图图啦啦完成签到 ,获得积分10
43秒前
白日梦完成签到,获得积分10
43秒前
斜阳完成签到 ,获得积分10
47秒前
2333完成签到 ,获得积分10
47秒前
量子星尘发布了新的文献求助10
52秒前
爆米花应助懂得瞧采纳,获得10
54秒前
mini完成签到 ,获得积分10
55秒前
健壮惋清完成签到 ,获得积分10
56秒前
机灵的听云完成签到,获得积分20
56秒前
xiao完成签到 ,获得积分10
56秒前
鹿靡完成签到,获得积分10
1分钟前
挤爆沙丁鱼完成签到,获得积分10
1分钟前
lf发布了新的文献求助10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI5应助科研通管家采纳,获得10
1分钟前
完美世界应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
mmyhn完成签到,获得积分10
1分钟前
懂得瞧发布了新的文献求助10
1分钟前
1分钟前
大个应助研友_Zzy1pn采纳,获得10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976600
求助须知:如何正确求助?哪些是违规求助? 3520689
关于积分的说明 11204470
捐赠科研通 3257316
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877881
科研通“疑难数据库(出版商)”最低求助积分说明 806613